WallStreetZenWallStreetZen

NASDAQ: VINC
Vincerx Pharma Inc Stock

$1.31-0.14 (-9.66%)
Updated Feb 3, 2023
VINC Price
$1.31
Fair Value Price
$3.48
Market Cap
$27.76M
52 Week Low
$0.63
52 Week High
$7.14
P/E
-0.49x
P/B
0.46x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$58.20M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.21
Operating Cash Flow
-$57M
Beta
0.43
Next Earnings
Mar 27, 2023
Ex-Dividend
N/A
Next Dividend
N/A

VINC Overview

Vincerx Pharma Incorparated is a biopharmaceutical company developing therapies to treat cancer. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating advanced cancers. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors, and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincex Pharma was founded in 2019 is headquartered in Palo Alto, CA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VINC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VINC ($1.31) is undervalued by 62.38% relative to our estimate of its Fair Value price of $3.48 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
VINC ($1.31) is significantly undervalued by 62.38% relative to our estimate of its Fair Value price of $3.48 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
VINC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more VINC due diligence checks available for Premium users.

Be the first to know about important VINC news, forecast changes, insider trades & much more!

VINC News

Valuation

VINC fair value

Fair Value of VINC stock based on Discounted Cash Flow (DCF)
Price
$1.31
Fair Value
$3.48
Undervalued by
62.38%
VINC ($1.31) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
VINC ($1.31) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
VINC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

VINC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.49x
Industry
10.7x
Market
15.09x

VINC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.46x
Industry
5.11x
VINC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VINC's financial health

Profit margin

Revenue
$0.0
Net Income
-$16.9M
Profit Margin
0%
VINC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$72.4M
Liabilities
$12.7M
Debt to equity
0.21
VINC's short-term assets ($67.26M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VINC's short-term assets ($67.26M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VINC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$14.9M
Investing
-$20.2M
Financing
$0.0
VINC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

VINC vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
VINC$27.76M-9.66%-0.49x0.46x
APRE$27.77M+0.58%-0.10x1.04x
EFTR$27.78M+19.46%0.54x2.40x
SHPH$27.58M-0.98%N/A3.28x
CYAD$28.02M-1.59%-0.93x0.90x

Vincerx Pharma Stock FAQ

What is Vincerx Pharma's quote symbol?

NASDAQ: VINC) Vincerx Pharma trades on the NASDAQ under the ticker symbol VINC. Vincerx Pharma stock quotes can also be displayed as NASDAQ: VINC.

If you're new to stock investing, here's how to buy Vincerx Pharma stock.

What is the 52 week high and low for Vincerx Pharma (NASDAQ: VINC)?

(NASDAQ: VINC) Vincerx Pharma's 52-week high was $7.14, and its 52-week low was $0.63. It is currently -81.65% from its 52-week high and 107.61% from its 52-week low.

How much is Vincerx Pharma stock worth today?

(NASDAQ: VINC) Vincerx Pharma currently has 21,189,769 outstanding shares. With Vincerx Pharma stock trading at $1.31 per share, the total value of Vincerx Pharma stock (market capitalization) is $27.76M.

Vincerx Pharma stock was originally listed at a price of $10.25 in Mar 6, 2020. If you had invested in Vincerx Pharma stock at $10.25, your return over the last 2 years would have been -87.22%, for an annualized return of -64.25% (not including any dividends or dividend reinvestments).

How much is Vincerx Pharma's stock price per share?

(NASDAQ: VINC) Vincerx Pharma stock price per share is $1.31 today (as of Feb 3, 2023).

What is Vincerx Pharma's Market Cap?

(NASDAQ: VINC) Vincerx Pharma's market cap is $27.76M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vincerx Pharma's market cap is calculated by multiplying VINC's current stock price of $1.31 by VINC's total outstanding shares of 21,189,769.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.